Date: Wednesday 21 Jan 2009
Abcam, a biosciences firm that markets antibodies online, said weakness in sterling contributed to strong trading in the six months to December 31 and expects full-year results to be ‘materially ahead of expectations.’
“The board remains confident in the prospects for continued growth, tempered only by an appreciation that even though the company should be reasonably resilient to any downturn the threat of global recession remains a risk for every business,” the firm said.
Email this article to a friend
or share it with one of these popular networks:
You are here: news